Drugs · acquisition-cost intelligence
All Day Allergy
Cetirizine· ingredient cetirizineOther antiallergics· CETIRIZINE HYDROCHLORIDE 1 mg/mL; CETIRIZINE HYDROCHLORIDE 5 mg/5mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.02152
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 10 weeks.
2025-09-172026-05-27
Same-ingredient options by acquisition cost
Other cetirizine products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| Cetirizine HCl | $0.04795 | +$0.02640 |
| 24 hour allergy | $0.06400 | +$0.04250 |
| 24 hour allergy | $0.19380 | +$0.17230 |
| 12 hour allergy d | $0.58890 | +$0.56740 |
| ZERVIATE | $7.33 | +$7.31 |
Medicare Part D coverage · CY2026
On 190 plan formularies · typical tier 2
Prior auth 0% · Step therapy 0% · Quantity limit 38% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.